Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach (original) (raw)
Medication Nonadherence in Diabetes: Longitudinal effects on costs and potential cost savings from improvement
Clara Dismuke
Diabetes Care, 2012
View PDFchevron_right
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Carl Asche
Clinical Therapeutics, 2011
View PDFchevron_right
Cost-Effectiveness Of Drug Compliance In Type 2 Diabetes Mellitus Patients
Gladys Lugo
Research journal of pharmaceutical, biological and chemical sciences, 2018
View PDFchevron_right
Does medication adherence lead to lower healthcare expenses for patients with diabetes?
Chin-hsiao Tseng
The American journal of managed care, 2013
View PDFchevron_right
An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence
Phillip Wiegand
Pharmacy Practice (Internet), 2008
View PDFchevron_right
A Multistate Model and an Algorithm for Measuring Long-Term Adherence to Medication: A Case of Diabetes Mellitus Type 2
Lise Aagaard, Majken Jensen
Value in Health, 2014
View PDFchevron_right
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes
Jui-Chen Yang
Patient Preference and Adherence, 2013
View PDFchevron_right
Antidiabetic therapy in real practice: indicators for adherence and treatment cost
Antonio Gaddi
Patient Preference and Adherence, 2012
View PDFchevron_right
Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling
Anne Neumann
Cost Effectiveness and Resource Allocation, 2011
View PDFchevron_right
Adherence and health care costs
Aurel Iuga
Risk Management and Healthcare Policy, 2014
View PDFchevron_right
Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study
Rita Berzin
BMJ Open Diabetes Research & Care, 2016
View PDFchevron_right
Association among change in medical costs, level of comorbidity, and change in adherence behavior
Steven Kymes
The American journal of managed care, 2016
View PDFchevron_right
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Robert Epstein
Medical Care, 2005
View PDFchevron_right
PDB59 Cost-Effectiveness Analysis of Medication Therapy Management in Patients with Type 2 Diabetes in Community Pharmacy/Ambulatory Care Settings: Results From a Decision-Analytic Markov Model
Mustafa Hussein
Value in Health, 2012
View PDFchevron_right
Economic impact of and treatment options for type 2 diabetes
Candis Morello
PubMed, 2017
View PDFchevron_right
Does Prescription Drug Adherence Reduce Hospitalizations and Costs?
Avi Dor
2010
View PDFchevron_right
Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice
Paulo Braga
Primary Care Diabetes, 2017
View PDFchevron_right
Patient adherence: a blind spot in cost-effectiveness analyses?
Alicen Burns Spaulding
The American journal of managed care, 2009
View PDFchevron_right
Estimating the Effect of Medication Adherence on Health Outcomes among Patients with Type 2 Diabetes—An Application of Marginal Structural Models
Andrew Yu
Value in Health, 2010
View PDFchevron_right
Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia
Jay Visaria
American Journal of Pharmacy Benefits
View PDFchevron_right
Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study)
Antoni Serrano-Blanco
BMC Primary Care, 2022
View PDFchevron_right
Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: A modeling study of cost-effectiveness in the United States
Wiliam Valentine
Advances in Therapy, 2007
View PDFchevron_right
Analysis of Financial Losses due to Poor Adherence of Patients with Chronic Diseases and Their Impact on Health Economics
Adina Turcu-Stiolica
Financial Management from an Emerging Market Perspective, 2018
View PDFchevron_right
Medication Nonadherence in Diabetes
Mulugeta Gebregziabher
Diabetes Care, 2012
View PDFchevron_right
Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents
Heather falvey
Diabetic …, 2009
View PDFchevron_right
Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada
Jaime Caro
Diabetic Medicine, 2004
View PDFchevron_right
Effectiveness and cost-effectiveness of diabetes prevention among adherent participants
Sharon Edelstein
The American Journal of Managed Care, 2013
View PDFchevron_right
Economic evaluation of type 2 diabetes prevention programmes: Markov model of low- and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia
Dawn Craig
BMC medicine, 2018
View PDFchevron_right
UKPDS 72 United Kingdom Prospective Diabetes Study. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72)
Alastair Gray
View PDFchevron_right
Short–run Associations Between Medical Care Expenditures and Adherence to Clinical Practice Guideline-based Measures for Diabetes
William Marder, Ronald J Ozminkowski
Value in Health, 2000
View PDFchevron_right
The Cost and Benefits of Treating Type 2 Diabetes Mellitus as a Chronic Condition
Robert Lieberthal
2005
View PDFchevron_right
Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013–2018
Elias Mossialos
2022
View PDFchevron_right
Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes
Pauline Lai
Patient Preference and Adherence, 2014
View PDFchevron_right